Compounds > lorazepam

lorazepam and Cardiovascular Diseases

lorazepam has been researched along with Cardiovascular Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amirnovin, R; Koh, JY; Lieu, P; Nelson, LP; Okuhara, C; Rodgers, JW; Sanchez-Pinto, LN1
Arnold, TC; Horowitz, BZ; Lange, RA; Richards, JR1
Domino, EF; Kothary, SP; Pandit, SK; Pandit, UA; Samra, SK1
Finkel, S1
Geller, RD; Samet, CM1

Trials

1 trial(s) available for lorazepam and Cardiovascular Diseases

ArticleYear
Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    The Journal of clinical psychiatry, 1978, Volume: 39, Issue:10 Pt 2

    Topics: Administration, Oral; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Lorazepam; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Time Factors

1978

Other Studies

4 other study(ies) available for lorazepam and Cardiovascular Diseases

ArticleYear
Implementation of a Risk-Stratified Opioid and Benzodiazepine Weaning Protocol in a Pediatric Cardiac ICU.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2018, Volume: 19, Issue:11

    Topics: Analgesics, Opioid; Benzodiazepines; Cardiovascular Diseases; Female; Humans; Hydromorphone; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Length of Stay; Lorazepam; Male; Methadone; Prospective Studies; Risk Assessment; Severity of Illness Index; Substance Withdrawal Syndrome

2018
Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol.
    The American journal of emergency medicine, 2017, Volume: 35, Issue:3

    Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Amphetamine-Related Disorders; Anti-Anxiety Agents; Anxiety; Cardiovascular Diseases; Cardiovascular System; Central Nervous System Stimulants; Chest Pain; Cocaine; Cocaine-Related Disorders; Drug Interactions; Electrocardiography; Humans; Hyperhidrosis; Labetalol; Lorazepam; Male; Methamphetamine; Sodium Chloride; Tachycardia; Young Adult

2017
Physostigmine fails to reverse clinical, psychomotor, or EEG effects of lorazepam.
    Anesthesia and analgesia, 1983, Volume: 62, Issue:7

    Topics: Adult; Anti-Anxiety Agents; Brain; Cardiovascular Diseases; Double-Blind Method; Electroencephalography; Female; Gastrointestinal Diseases; Glycopyrrolate; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory; Physostigmine; Psychomotor Performance

1983
Anxiety associated with cardiovascular disorders: a study using lorazepam.
    Psychosomatics, 1979, Volume: 20, Issue:10

    Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Lorazepam; Male; Middle Aged

1979